Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segmen…
13k employees bausch.com
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-05-19
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
News release - English.pdf
News 2026-05-06
Bausch + Lomb Announces Second R&D "Teach-in" Webinar
News release - English.pdf
News 2026-04-30
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
News release - English.pdf
Results 2026-04-29
Interim MD&A - English.pdf
Results 2026-04-29
Interim financial statements/report – English.pdf
Results 2026-04-29
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
News release - English.pdf
Ownership 2026-04-27
2 insiders · −$317k net
Insider trading – 2026-04-27
2 insiders · −$317k net
News 2026-04-08
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™™ Advanced Update
News release - English.pdf
News 2026-04-07
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
News release - English.pdf
News 2026-04-06
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
News release - English.pdf
Results 2026-03-23
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
News release - English.pdf
Ownership 2026-03-10
3 insiders · +$571k net
Insider trading – 2026-03-10
3 insiders · +$571k net
Ownership 2026-03-04
Ross Sr., Thomas bought +$80k
Insider trading – 2026-03-04
1 insider · +$80k net
Ownership 2026-03-03
5 insiders · −$1.3M net
Insider trading – 2026-03-03
5 insiders · −$1.3M net
Ownership 2026-03-02
7 insiders · −$1.8M net
Insider trading – 2026-03-02
7 insiders · −$1.8M net
News 2026-02-28
Code of conduct.pdf
Ownership 2026-02-25
Saunders, Brenton Lawrence sold +$1.2M
Insider trading – 2026-02-25
1 insider · −$1.2M net
News 2026-02-24
Bausch + Lomb: Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
News release - English.pdf
Ownership 2026-02-24
Robertson, Russel Clark bought +$79k
Insider trading – 2026-02-24
1 insider · +$79k net
Ownership 2026-02-23
Ling, Karen bought +$71k
Insider trading – 2026-02-23
1 insider · +$71k net
Results 2026-02-18 Financials
Annual information form - English.pdf
Results 2026-02-18 Financials
Annual MD&A - English.pdf
Results 2026-02-18 Financials
Audited annual financial statements – English.pdf
Results 2026-02-18
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
News release - English.pdf
Transactions 2026-01-02
Material contracts - Credit agreements.pdf
Transactions 2026-01-02 Financing
Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
News release - English.pdf
Transactions 2025-12-12 Financing
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
News release - English.pdf
News 2025-11-13
Other.pdf
News 2025-11-13
News release - English.pdf
Results 2025-10-29 Financials
Interim financial statements/report – English.pdf
Results 2025-10-29 Financials
Interim MD&A - English.pdf
News 2025-10-29
News release - English.pdf
News 2025-09-29
News release - English.pdf
News 2025-09-11
News release - English.pdf
News 2025-09-09
News release - English.pdf
News 2025-09-08
News release - English.pdf
News 2025-08-18
News release - English.pdf
News 2025-08-14
News release - English.pdf
Ownership 2025-08-07
Saunders, Brenton Lawrence sold +$61k
Insider trading – 2025-08-07
1 insider · −$61k net
Results 2025-07-30 Financials
Interim MD&A - English.pdf
Results 2025-07-30 Financials
Interim financial statements/report – English.pdf
News 2025-07-30
News release - English.pdf
News 2025-07-29
News release - English.pdf
Ownership 2025-07-28
4 insiders · −$145k net
Insider trading – 2025-07-28
4 insiders · −$145k net
News 2025-06-30
News release - English.pdf
Transactions 2025-06-27
Other material contracts - English.pdf
Transactions 2025-06-27
Material contracts - Credit agreements.pdf
News 2025-06-27
Other.pdf
News 2025-06-26
News release - English.pdf
News 2025-06-18
News release - English.pdf
Ownership 2025-06-16
Bonnefoy, Luc sold +$12k
Insider trading – 2025-06-16
1 insider · −$12k net
News 2025-06-10
Other.pdf
News 2025-06-10
News release - English.pdf
News 2025-06-04
News release - English.pdf
Ownership 2025-05-27
Saunders, Brenton Lawrence bought +$248k
Insider trading – 2025-05-27
1 insider · +$248k net
Ownership 2025-05-06
Von Eschenbach, Andrew Charles bought +$20k
Insider trading – 2025-05-06
1 insider · +$20k net
Ownership 2025-04-25
2 insiders · −$191k net
Insider trading – 2025-04-25
2 insiders · −$191k net
Ownership 2025-03-03
Bonnefoy, Luc sold +$66k
Insider trading – 2025-03-03
1 insider · −$66k net
Ownership 2024-12-27
6 insiders · −$2.3M net
Insider trading – 2024-12-27
6 insiders · −$2.3M net
Ownership 2024-08-07
Saunders, Brenton Lawrence bought +$503k
Insider trading – 2024-08-07
1 insider · +$503k net
Ownership 2024-07-29
4 insiders · −$177k net
Insider trading – 2024-07-29
4 insiders · −$177k net
Ownership 2024-06-18
Bonnefoy, Luc sold +$14k
Insider trading – 2024-06-18
1 insider · −$14k net